Product NDC: | 58468-0181 |
Proprietary Name: | Leukine |
Non Proprietary Name: | sargramostim |
Active Ingredient(s): | 500 ug/mL & nbsp; sargramostim |
Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
Dosage Form(s): | LIQUID |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 58468-0181 |
Labeler Name: | Genzyme Corporation |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103362 |
Marketing Category: | BLA |
Start Marketing Date: | 20100315 |
Package NDC: | 58468-0181-1 |
Package Description: | 1 VIAL in 1 CARTON (58468-0181-1) > 1 mL in 1 VIAL |
NDC Code | 58468-0181-1 |
Proprietary Name | Leukine |
Package Description | 1 VIAL in 1 CARTON (58468-0181-1) > 1 mL in 1 VIAL |
Product NDC | 58468-0181 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | sargramostim |
Dosage Form Name | LIQUID |
Route Name | INTRAVENOUS; SUBCUTANEOUS |
Start Marketing Date | 20100315 |
Marketing Category Name | BLA |
Labeler Name | Genzyme Corporation |
Substance Name | SARGRAMOSTIM |
Strength Number | 500 |
Strength Unit | ug/mL |
Pharmaceutical Classes | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |